Alzheimer's Essay

Alzheimer disease (AD) is the most common cause of dementia in the elderly, accounting for 65–70% of all cases (Jellinger, Janetzky, Attems, & Kienzl, 2008). The other dementias are of the Parkinson 's group, the fronto-temporal group and the vascular group. The total worldwide yearly costs for the treatment and care of patients suffering from dementia are estimated to be around 250 billion US dollars. The lifetime risk for AD between the ages of 65 and 100 is 33% for men and 45% for women with an annual increase of 1–2% in the seventh decade to almost 60% in the 10th decade with doubling every 5 years (Jellinger et al., 2008). AD is incurable, and thus represents a major public health problem. AD represents a challenge to humanity due to its relatively recent discovery, progressive nature of the illness, and complex diagnosis.

In times past many people thought that memory loss was a normal occurrence for elderly people. This thinking was major reason for why Alzheimer’s disease was not caught until very later in the stages. Alzheimer’s disease is not a normal part of aging. After heart disease, cancer, and strokes, Alzheimer’s is the most common cause of death in adults in the Western world. “It is estimated that 4.5 million Americans over the age of 65 are affected with this condition. After the age of 65, the incidence of the disease doubles every five years and, by age 85, it will affect nearly half of the population” (Robinson).

The disease called Alzheimer’s is the fourth leading cause of death in the United States (Weiner, 1987). It is estimated that the elderly population will double between now and 2030. During this period, the number of elderly will grow by an average of 2.8% annually (U.S. Census Bureau, 2001). By 2050, the number of people with Alzheimer’s is estimated to range from 11.3 million to 16 million (Alzheimer’s Association, 2005). These startling numbers should prompt an examination into one of the leading causes of death among this group of people. Understanding what Alzheimer’s is and the known causes of the disease are a good starting point. For those who have aging family members, knowing the risk factors and warning

Dementia does not only impact the people with symptoms and it also disturbs the people who must care for the person. It is estimated that 1.2 million people are involved in the care of people with dementia. It has a financial burden on the Australian economy $4.9 billion in 2009-10. (1)

By the numbers, Alzheimer’s disease looks even worse than it may be. The cost of Alzheimer’s overwhelms the caregiver and everyone involved with the patient. The price businesses pay for Alzheimer’s it detrimental to their industry, show by “A 2002 study showed that United States businesses lost $36.5 billion that year because employees missed work or quit and had to be replaced so that they could care for someone with Alzheimer’s disease” (Adams 24). The caregivers play vital roles in the lives of the sufferer, but the business take an even heavier loss. Heath care is necessary for someone with Alzheimer’s disease, however it can get expensive “The costs of

The likelihood of developing Alzheimer’s doubles every year and recent studies have found that women are more likely to be diagnosed with Alzheimer’s then men (Medicine).

The interventions used should aim to slower those cognitive, behavioral and functional symptoms of Alzheimer so that we can reduce the costs on social care, rate of hospitalization and other direct, indirect and intangible costs. The treatments provided should also focus on the Incremental Cost-Effectiveness Ratio (ICER) and Quality Adjusted Life Year (QALY) gained after patients undergo treatments so that the effectiveness of certain intervention can be identified and

Alzheimer’s disease is a complex illness that affects the brain tissue directly and undergoes gradual memory and behavioral changes which makes it difficult to diagnose. It is known to be the most common form of dementia and is irreversible. Over four million older Americans have Alzheimer’s, and that number is expected to triple in the next twenty years as more people live into their eighties and nineties. (Johnson, 1989). There is still no cure for Alzheimer’s but throughout the past few years a lot of progress has been made.

A major devastating and debilitating disease, Alzheimer 's is a public health issue that affects not only the United States but also countries all around the world. In 2010, there were 35.6 million people living with Alzheimer’s. Researchers and medical personnel expect this number to triple by the year 2050. The disease is costing America an exorbitant amount of money and has become a burden on families, caregivers, medical personnel, the healthcare system, and the nation’s economy. If attention is not focused on this major problem, “nursing homes will be overloaded, caregivers will be burned out, healthcare system will be overwhelmed, and federal and state budgets will be overtaxed” (Alzheimer’s Association, 2011).

     Those diagnosed with Alzheimer’s disease usually end up in nursing homes or hospice care centers, because, as the disease evolves to its later stages, the patient typically becomes unable to care for themselves and is required to have around-the-clock care. Nursing care is very expensive and can be estimated to cost “…approximately $47,000 per patient per year” (Cummings and Cole 1). Patients are plagued with not only memory loss, but also abnormalities of the motor system, problems assessing new information, trouble speaking and disorientation. “Patients with AD usually survive 7-10

The objective of this research paper will be to explore available long-term services, long-term facilities and their levels of service, and financing for individuals who are facing the challenge of Alzheimer 's disease. This is an important topic that affects me personally and professionally as well as having lasting effects on our community.

Alzheimer 's disease is a progressive deterioration of cognitive function sufficient to cause functional disability (Hannaman, Mitchell, Cross, 2011). It is the most common cause of dementia after age 60 with initial signs reflective of hippocampal dysfunction, with poor immediate recall and short-term memory. "As the disease progresses, visuospatial dysfunction (including with directions and geographic disorientation), due to parietal lobe involvement, and executive dysfunction (including difficulty initiating and completing tasks, reduced spontaneity, and apathy). due to frontal dysfunction typically appear" (Hannaman, Mitchell, Cross, 2011, p. 11-6). Median survival rate is 3 years because of

Alzheimer’s is a degenerate disease of the brain. There are an estimated four million Americans that live with Alzheimer’s, it is believed that the disease accounts anywhere from 50 to 70 percent of all cases of dementia (UCSF medical center). The vast amount of cases leads me to believe that we would not need to look very far to find either a friend or family member distant or close that has had a personal or familial experience with this disease.

The Journal of the American Medical Association reports the latest break through in the study of gene causing Alzheimer’s has pointed to two genes, chromosomes 2 and 19 that cause the disease (7). The article also points out another gene, A polipoprotein E-e4, is also linked to Alzheimer’s disease. According to the Journal of Alzheimer’s disease, Jose Vina and Ana Lloret writes that women are at higher risk of Alzheimer’s due

Alzheimer is a disease that affects the elderly most. The disease was discovered by Dr. Alois Alzheimer in the year 1906 when he was examining a female’s brain. He found out that the woman displayed memory loss, language problems and some inexplicable changes in behavior. The disease was named after the doctor who was a German psychiatrist and a neuropathologist. Alzheimer’s disease is a degenerative brain disorder that leads to memory loss, personality changes, and language problems (Gilbert & Julie 2). The disease is mostly diagnosed in people over the age of 65 years, though there is a small minority of people under the age of 50 who get the disease. Studies show that 1% of a whole population aged between the ages 65-75 have severe